BETHESDA, Md.--(BUSINESS WIRE)--United BioSource Corporation (UBC) today announced results from an independent survey that examined late phase product development services delivered by 34 contract research organizations and other scientific and medical affairs companies serving the biopharmaceutical industry. The report, titled 2010 Late Phase Market Dynamics and published by Industry Standard Research (ISR), provided data and analysis from a survey that captured information from 149 respondents, representing 95 companies. Survey respondents ranked UBC above all competitors including top 10 contract research organizations on key performance measures, including: 1) overall satisfaction with service providers, 2) willingness to recommend to colleagues or friends; and 3) likelihood to use a service provider again.
